Company: CERO
Filing Date: 2025-02-07
Form Type: 424B3
Source: 0001213900-25-011071
Chunk: 7

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-02-07
Form: 424B3
Chunk 7
---
 February 23, 2024, by and between CERo and Arena.

“Board”
refers to the board of directors of CERo.

“Business Combination”
refers to the transactions contemplated by the Business Combination Agreement, including the merger between Merger Sub and Legacy CERo.

“Business Combination Agreement” refers to the Business Combination Agreement, dated as of June 4, 2023, as amended by Amendment No. 1, dated February
5, 2024 and Amendment No. 2, dated February 13, 2024, by and between PBAX, Merger Sub and Legacy CERo.

“Bylaws”
refers to the Amended and Restated Bylaws of CERo.

“Charter”
refers to CERo’s Second Amended and Restated Certificate of Incorporation, as filed with the Secretary of the State of Delaware
February 14, 2024.

“Class A Common Stock” refers to the PBAX Class A common stock, par value $0.0001 per share.

“Closing”
refers to the closing of the Business Combination.

“Commitment Shares”
refers to the Arena Commitment Shares and the Keystone Commitment Shares.

“Common Stock”
refers to the common stock, par value $0.0001 per share, of CERo.

“Common Warrants”
refers to the Public Warrants, Private Placement Warrants, the Conversion Warrants, the Series A Warrants and the Series C Warrants.

“Conversion Warrants”
refer to the warrants initially issued by CERo Therapeutics, Inc. and converted into warrants to purchase Common Stock in connection
with the Business Combination.

“Convertible Bridge Notes” refer to the senior secured convertible notes issued by Legacy CERo to certain Legacy CERo Stockholders, which automatically
converted into shares of Common Stock upon Closing.

“Danforth”
refers to Danforth Advisors, LLC.

“DGCL”
refers to the Delaware General Corporation Law, as may be amended from time to time.

“dollars”
or “$” refers to U.S. dollars.

“Earnout Shares”
refer to the Primary Earnout Shares, the Secondary Earnout Shares and the Tertiary Earnout Shares, collectively.

<div align='center'>v</div>

“Exchange Act”
refers to the Securities Exchange Act of 1934, as amended.

“FDA”
refers to the U.S. Food and Drug Administration, or any successor